Analytical Technology Introductions Planned for Pittcon 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Analytical Technology Introductions Planned for Pittcon 2013


The Pittcon 2013 Exposition, which takes place March 17-21 at the Pennsylvania Convention Center in Philadelphia, features emerging analytical technologies for analytical chemistry, drug discovery and development, nanotechnology, life sciences, and other disciplines. Instrument manufacturers frequently introduce new products or announce updates to current technologies at the event.

The exposition floor includes 1,926 booths and 18 seminar rooms, hosting 1,011 exhibitors (as of March 1, 2013) displaying products and services used by the scientific community in industrial, academic, and government labs. A mini-museum display of instrumentation, presented by the Chemical Heritage Foundation, celebrates the 100th anniversary of mass spectrometry.

The conference program features workshops, symposia, and short courses on chromatography, molecular and atomic spectroscopy, electrochemistry, mass spectrometry, and lab-on-chip technology.

Waters Corp. Updates Instruments and Software

Shimadzu Scientific Instruments Adds Chromatography Instruments and Software

Thermo Fisher Scientific Introduces Software, Instruments, and Consumables

Mettler Toledo Introduces Mechanical Analyzer

Rigaku Raman Upgrades Handheld Analyzer

Bruker Introduces Mass Spectrometers, NMR Modules

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here